Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Journal of Clinical Pharmacology
|
November 1, 1988
Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine
W K Cheung, L L Sia, D L Woodward, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1989
Skin metabolism and transdermal absorption of viprostol, a synthetic PGE2 analog, in the rat: effect of vehicle
G Nicolau, D C Dahlin, M Kohlbrenner, et al.
The American Journal of Cardiology
|
February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias
H J Duff, D M Roden, A Yacobi, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1999
A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine
A Yacobi, S Zlotnick, J L Colaizzi, et al.
Journal of Clinical Pharmacology
|
August 1, 1988
Absolute bioavailability of cefixime in man
R D Faulkner, P Fernandez, G Lawrence, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1991
Workshop report on in vivo percutaneous penetration/absorption. Washington D.C., May 1-3, 1989
V P Shah, G L Flynn, R H Guy, et al.
Pharmaceutical Research
|
August 1, 1991
In vivo percutaneous penetration/absorption, Washington, D.C., May 1989
V P Shah, G L Flynn, R H Guy, et al.
Journal of Pharmaceutical Sciences
|
September 1, 1980
Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans
A Yacobi, R G Stoll, G C Chao, et al.
Journal of Pharmaceutical Sciences
|
September 1, 1990
Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms
J P Skelley, G L Amidon, W H Barr, et al.
Journal of Clinical Pharmacology
|
August 10, 2000
Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin
A Yacobi, E Masson, D Moros, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Journal of Clinical Pharmacology
|
November 1, 1988
Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine
W K Cheung, L L Sia, D L Woodward, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1989
Skin metabolism and transdermal absorption of viprostol, a synthetic PGE2 analog, in the rat: effect of vehicle
G Nicolau, D C Dahlin, M Kohlbrenner, et al.
The American Journal of Cardiology
|
February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias
H J Duff, D M Roden, A Yacobi, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1999
A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine
A Yacobi, S Zlotnick, J L Colaizzi, et al.
Journal of Clinical Pharmacology
|
August 1, 1988
Absolute bioavailability of cefixime in man
R D Faulkner, P Fernandez, G Lawrence, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society
|
January 1, 1991
Workshop report on in vivo percutaneous penetration/absorption. Washington D.C., May 1-3, 1989
V P Shah, G L Flynn, R H Guy, et al.
Pharmaceutical Research
|
August 1, 1991
In vivo percutaneous penetration/absorption, Washington, D.C., May 1989
V P Shah, G L Flynn, R H Guy, et al.
Journal of Pharmaceutical Sciences
|
September 1, 1980
Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans
A Yacobi, R G Stoll, G C Chao, et al.
Journal of Pharmaceutical Sciences
|
September 1, 1990
Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms
J P Skelley, G L Amidon, W H Barr, et al.
Journal of Clinical Pharmacology
|
August 10, 2000
Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin
A Yacobi, E Masson, D Moros, et al.
Page
of 12